国际标准期刊号: 2165-7904

肥胖与减肥治疗杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 国际农业与生物科学中心 (CABI)
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • SWB 在线目录
  • CABI 全文
  • 出租车直达
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 布里斯托大学
  • 出版医学
  • ICMJE
分享此页面

抽象的

Roux en Y Gastric Bypass after Failed Primary Restrictive Procedures in Morbidly Obese Patients

Amr Elgazar, Sheref A El Seidy, Medhat Khalil, Haitham Elmaleh, Debvarsha Mandel, Ahmed K Awad, Alaa Abbass

Background: Worldwide prevalent over the past several decades, Obesity morbidities and health related adverse effects has been an increasing concern that lead to revolutionary advancements in the field of bariatric surgery. The long-term outcomes of the different techniques in have gained popularity in the last years. Although sleeve gastrectomy is being performed with increasing frequency as well as other restrictive procedures, failure or inadequate satisfactory outcome of these procedures became interestingly evident and thoroughly studied ranging from regaining of the preliminary lost weight, insufficient weight loss, GERD, and various other complications all of which determine a failure of the primary procedure.

Methods: In this prospective study 40 patients were included who underwent a revisional Roux-en-Y gastric bypass after failure of a different primary restrictive procedures (17 patients underwent sleeve gastrectomy, 21 patients underwent VBG and 2 patients underwent adjustable gastric banding) from January 2018 till January 2019 with a follow up period of one year till January 2020.

Results: Each patient had different indication for the revisional Roux en y gastric bypass conversion: 18 patients (45%) due to weight regain after 1ry weight loss, 14 patients (35%) due to insufficient weight loss, and 8 patients (20%) due to GERD. Roux en y gastric bypass was performed with significant reduction of both mean weight of the patients from 113.50 ± 9.92 kg to 98.65 ± 9.93 and 89.18 ± 9.84 after 6, and 12 months respectively and mean BMI from 39.06 ± 4.91 before the conversion to 33.93 ± 4.44 and 30.65 ± 4.11 at 6 and 12 months respectively. Moreover, co-morbidities such as Diabetes and Hypertension were markedly improved in addition to the lipid profile of most of the patients.

Conclusion: Roux en y gastric bypass is a safe surgical procedure with satisfactory outcomes and can be proposed as first line management choice to revise failed primary restrictive bariatric procedures.